title: Fluoride ion toxicity in human kidney collecting duct cells.
abstract: BACKGROUND
  Several halogenated anesthetics induce a urinary concentrating defect, partly related to fluoride ion toxicity in collecting duct cells. The aim of this study was to investigate the effects of fluoride ion in human kidney cells.
  
  
  METHODS
  Immortalized human collecting duct cells were used. In a first set of experiments, the toxicity threshold concentration was determined by exposing cell cultures for 24 h to increasing concentrations of fluoride ion in the medium: 0, 1, 5, and 10 mM. The second set of experiments was a time- effect study in which cells were exposed to 5 mM fluoride for 2, 6, and 24 h. Assessment of toxicity was based on several endpoints: cell number, protein content, (3)H-leucine incorporation in newly synthesized proteins, extracellularly released lactate dehydrogenase, Na-K-ATPase pump activity, and electron microscope studies.
  
  
  RESULTS
  After 24 h of exposure, fluoride ion decreased cell number (-23%, P<0.05), total protein content (-30%, P<0.05) and increased lactate dehydrogenase release (+236%, P<0.05) at a threshold concentration of 5mM. Fluoride ion also inhibited Na-K- ATPase activity at 5 mM (-58%, P<0.05). Major morphologic alterations of mitochondria, including crystal formation, were detected from 1 mM fluoride concentration. Time-effect studies showed that, after only 6 h of exposure at 5 mM, fluoride decreased cell number (-13%, P<0.05), (3)H-leucine incorporation (-48%, P<0.05), and Na-K-ATPase activity (- 20%, P<0.05) and increased lactate dehydrogenase release (+145%, P<0.05). Crystal deposits in mitochondria again were a more sensitive marker of cell injury, detectable after only 2 h of exposure.
  
  
  CONCLUSIONS
  these results suggest that the mitochondrion is a target of fluoride toxicity in human collecting duct cells, and its alteration is partly responsible for the sodium and water disturbances observed in patients.
authors.affiliation: Departement d'Anesthesie-Reanimation, Hopital Pitie-Salpetriere, Paris, France.
authors.forename: M L
authors.initials: ML
authors.lastname: Cittanova
authors.forename: B
authors.initials: B
authors.lastname: Lelongt
authors.forename: M C
authors.initials: MC
authors.lastname: Verpont
authors.forename: M
authors.initials: M
authors.lastname: Geniteau-Legendre
authors.forename: F
authors.initials: F
authors.lastname: Wahbe
authors.forename: D
authors.initials: D
authors.lastname: Prie
authors.forename: P
authors.initials: P
authors.lastname: Coriat
authors.forename: P M
authors.initials: PM
authors.lastname: Ronco
mesh_terms: D018685:Anesthetics, Inhalation / Q000633:toxicity*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D005459:Fluorides / Q000633:toxicity*; D006801:Humans; D007685:Kidney Tubules, Collecting / Q000187:drug effects* / Q000201:enzymology / Q000648:ultrastructure; D008854:Microscopy, Electron; D008928:Mitochondria / Q000187:drug effects / Q000648:ultrastructure; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
chemical_list: D018685:Anesthetics, Inhalation; D000254:Sodium-Potassium-Exchanging ATPase; D005459:Fluorides